Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial.
about
Akt and autophagy cooperate to promote survival of drug-resistant gliomaAutophagy in colorectal cancer: An important switch from physiology to pathologyConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesTargeting autophagy in cancer management - strategies and developmentsChloroquine and hydroxychloroquine for cancer therapyPhotoreceptor cell death and rescue in retinal detachment and degenerationsYou eat what you are: autophagy inhibition as a therapeutic strategy in leukemiaDrug repurposing and human parasitic protozoan diseasesAutophagy: a targetable linchpin of cancer cell metabolismIDO2 in Immunomodulation and Autoimmune DiseaseChaperone-mediated autophagy: roles in neurodegenerationTumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapyTargeting autophagy to sensitive glioma to temozolomide treatmentGlioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois'Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsAutophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumorsIdentification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cellsThymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cellsChloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosisAutophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohortCurrent data and strategy in glioblastoma multiformeAutophagy-Regulating microRNAs and CancerCardiomyocyte autophagy and cancer chemotherapy.Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivoAutophagy: cerebral home cooking.Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis.STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth.Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenibHexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cellsRepurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentAutophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.New concepts in antimalarial use and mode of action in dermatology.Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1.Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells.Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelChloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote γ-irradiation-induced cell death in primary stem-like glioma cellsCoordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma.
P2860
Q24629677-2C1BED65-8E34-47EC-8431-EB1EA0821F96Q26776207-59DE115C-A84E-4815-A088-10D5A356CABEQ26781215-7B7C9EA8-DCC1-45F9-8ECD-8D6E888DD8EEQ26782468-3B04D1A3-D554-49DD-A006-EFD87850FD26Q26827797-B39572A4-73DF-418B-BB4B-348E74D7D405Q26853192-260AA742-393A-4D27-8C8D-66B670DE9898Q26998971-A4A344E1-CFF7-45E8-8B62-B5495C7D3F62Q26999453-07BFB4BF-10C9-4541-9D2D-68424769EC55Q27004020-9390B219-92E5-4452-BC9A-6DD2D158CF38Q27006786-38838FF2-9446-4996-91E8-8D467157583BQ27016100-D9B55265-1A76-4B84-BAD5-D13045883887Q27024127-C190DFC9-2514-4FDD-B3E6-7AB00B1AC7E8Q28066270-2E9B36F1-A136-4F9D-BD7E-A2CC15A37CCFQ28067399-64248122-BCB5-425E-B4C5-86EE85F00261Q28393898-A45B4529-3E62-4296-B5CA-9281BE604D49Q28468571-BA633536-C8E6-42C0-8F75-BB9829EE10B8Q28480517-AD3FDAA3-7BCA-4BC9-857F-8A334C43630AQ28536969-78172D55-2758-4F72-AE01-9EF6B37D6017Q28829690-DF35DFEF-91A7-441A-919E-97B31C83A053Q30584653-436CE2B5-113F-4F74-ABB7-E8E63F37E498Q33416266-F2B7511C-0788-41DF-8115-0EEC723113F8Q33422577-F216AB19-197C-4D15-8B2C-AC13014520B1Q33527073-06008FDA-8A45-43EE-B9BF-DD80789F8FA4Q33572337-D9881C1E-187A-4743-BBCE-B1FBEB6F3D74Q33573823-17FAE080-7E3C-422F-88BD-34A656F40604Q33675791-46F4D310-5EFE-4C9F-9EEE-0871CD8DBF63Q33703592-6C5A65C7-601B-4D63-8BEA-932DFCA37D3CQ33727550-44EEDA9A-7DA7-4DB5-A818-0DC9B96CE670Q33757027-3725001D-9CE8-4044-923F-4CFED348D2C0Q33878944-FAA9DC36-1BF8-4339-A190-ACCAAD08E2E1Q33880100-193C9177-D14E-44D0-9CEB-4310A24860DAQ33893928-C4D8B55A-8C0D-49AB-B017-58C5E8C72338Q33937865-88181095-0E61-4168-91DF-027EDCB5966DQ34007922-5A49859D-C6F7-4262-843E-957C9B246D20Q34066920-2CAD2129-8E15-479F-B49B-A8DD7E2E786BQ34096767-41FB8C16-F2E3-4478-81F4-BE9C8EB4201AQ34309146-52C47CA5-6EEA-4756-9267-31C81BF7C99CQ34411761-CF29BDEC-FB1D-4ED0-9FE5-176888599F9EQ34455213-BC85FC90-DD42-4B4A-BF8B-1B6D2EC1D833Q34576062-4222EC1C-3717-440E-9925-DCCAB3834CAF
P2860
Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@ast
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@en
type
label
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@ast
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@en
prefLabel
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@ast
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@en
P2093
P1476
Adding chloroquine to conventi ...... ind, placebo-controlled trial.
@en
P2093
Eduardo Briceño
Julio Sotelo
Miguel Angel López-González
P304
P356
10.7326/0003-4819-144-5-200603070-00008
P407
P577
2006-03-01T00:00:00Z